New Research on BV and a Possible Link to Chlamydia

A woman talks with her health care provider

Bacterial vaginosis (BV) is a common gynecological infection. BV is caused when the “good” and “bad” bacteria that naturally live in the vagina become out of balance. Some women will have no symptoms of a BV infection, but others may experience itching, irritation, and abnormal discharge. BV is not a sexually transmitted infection (STI), but when left untreated it can increase the risk of contracting other STIs including chlamydia, HPV, and HIV.

A new study from Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Medicine at Mount Sinai looked at the vaginal microbiome of young women to try to better understand the link between BV and STIs. It found that there are two distinct types of BV infection, one of which increases the risk of chlamydia infection. The researchers think this discovery could one day change how we screen for and treat BV.

The Study

Researchers recruited 560 adolescent and young adult women who were Black or Latina. Both BV and chlamydia are more common among women in these communities. They took samples of vaginal and cervical fluid from participants who did not have chlamydia, from those who had a current infection, and from those who had recently been treated with antibiotics. DNA sequencing of the samples allowed them to identify the two types of BV.

Dr. Robert Burk, who served as co-lead on this study, explained, “This research shows that specific changes in the cervicovaginal microbiome set the stage for chlamydia. And it shows that targeting treatment against the more-dangerous BV subtype could potentially prevent many women from developing chlamydia, which is particularly prevalent in historically underserved communities.”

Health care providers don’t yet have the technology to test for which type of BV a person has, but Burk and his colleagues envision a future where there is more regular testing for BV and high-risk types are treated immediately. “We can now determine which BV cases are most worrisome and should be closely monitored. Detecting and treating these infections could substantially reduce the incidence of chlamydia and its serious consequences including pelvic inflammatory disease, infertility, and miscarriage,” Burk explained.

More research has to be done, however, before this can become the standard for testing and treatment.

In the meantime, it’s important for women to see a provider whenever they have symptoms of vaginal itching, burning, or irritation. It could be a yeast infection, BV, or an STI such as chlamydia or gonorrhea. Getting diagnosed and treated as soon as possible can relieve symptoms, prevent long-term complications, and help stop the spread of STIs.

It’s also important that people who are sexually active get regularly tested for STIs like chlamydia or gonorrhea because they often have no symptoms. The CDC recommends, for example, that sexually active young women under 25 get screened for chlamydia at least once each year.

More to Explore

Three condoms

Learn About Condoms

Currently, condoms are the only widely available, proven method for preventing pregnancy and reducing transmission of HIV and other sexually transmitted infections (STIs) during sex. Condoms work.

A stethoscope hangs over file folders

HPV Screening with Self Collection Endorsed by Two Organizations

At the end of 2025, the American Cancer Society released its new cervical cancer screening guidelines. In January 2026, the Health Resources and Services Administration endorsed a new set of guidelines as well. Both suggest HPV screening with self collected samples is an acceptable option.

Australia

Australia is Closer to Ending Cervical Cancer

Australia has been a leader in HPV-prevention and cervical cancer screening for decades. Because of this, it is now close to eliminating cervical cancer entirely. However, recent drops in vaccination and screening rates threaten this progress.

Gonorrhea

There Are Two New Drugs to Treat Gonorrhea 

The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.

A stethoscope and a teal ribbon

ACS Releases New Cervical Cancer Screening Guidelines

The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.